HB172 - Relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.
New Hampshire - 2024 Regular Session
Introduced byJess Edwards, Peter R. Leishman
Last updated over 1 year ago
2 Co-Sponsors
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now